ICD-10 Coding for Positive Antinuclear Antibody Test(R76.0, R76.0B, R76.0R)
Learn about ICD-10 coding for positive ANA tests, including documentation requirements and common coding pitfalls.
Complete code families applicable to Positive Antinuclear Antibody Test
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R76.0 | Raised antibody titer | Use when ANA titer is elevated but no specific pattern is identified. |
|
| R76.8 | Other abnormal immunological findings in serum | Use when specific ANA patterns are identified. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPositive Antinuclear Antibody Test
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Positive Antinuclear Antibody Test.
Failing to document specific ANA pattern.
Impact
Clinical: May lead to misinterpretation of patient condition., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials due to insufficient documentation.
Mitigation
Always review lab reports for pattern details., Educate staff on documentation standards.
Using R76.0 as a principal diagnosis when a definitive autoimmune condition is present.
Impact
Reimbursement: Incorrect sequencing may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient condition.
Mitigation
Sequence the definitive condition code first, followed by R76.0.
Documentation of ANA patterns
Impact
Failure to document specific ANA patterns can lead to audit issues.
Mitigation
Ensure all lab results are accurately documented in patient records.